Cargando…
Evaluating of HPV–DNA ISH as an adjunct to p16 testing in oropharyngeal cancer
AIM: Current guidelines recommend p16 immunohistochemistry (IHC) for testing human papillomavirus (HPV) in oropharyngeal carcinoma (OPSCC). We evaluated the value of adding DNA in situ hybridization (ISH) to p16 IHC. METHODS: Fifty patients with OPSCC were analyzed. Concordance between HPV–DNA ISH a...
Autores principales: | Chi, Jeffrey, Preeshagul, Isabel R, Sheikh-Fayyaz, Silvat, Teckie, Sewit, Kohn, Nina, Ziemba, Yonah, Laser, Alice, Frank, Douglas, Ghaly, Maged, Kamdar, Dev, Kraus, Dennis, Paul, Doru, Seetharamu, Nagashree |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668141/ https://www.ncbi.nlm.nih.gov/pubmed/33235805 http://dx.doi.org/10.2144/fsoa-2020-0052 |
Ejemplares similares
-
Simple parameters to solve a complex issue: predicting response to checkpoint inhibitor therapy in lung cancer
por: Newman, James, et al.
Publicado: (2020) -
Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer
por: Vempati, Prashant, et al.
Publicado: (2020) -
New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab
por: Seetharamu, Nagashree, et al.
Publicado: (2017) -
Optimizing Tissue Use: A Step-wise Approach to Diagnosing Squamous Cell Lung Carcinoma on Small Biopsies
por: Olazagasti, Coral, et al.
Publicado: (2020) -
Radiation recall pneumonitis in the setting of immunotherapy and radiation: a focused review
por: McGovern, Kerri, et al.
Publicado: (2019)